291 related articles for article (PubMed ID: 9403621)
41. The cardiac endothelin system in established pressure overload left ventricular hypertrophy.
Schunkert H; Orzechowski HD; Böcker W; Meier R; Riegger GA; Paul M
J Mol Med (Berl); 1999 Aug; 77(8):623-30. PubMed ID: 10543394
[TBL] [Abstract][Full Text] [Related]
42. Endothelin antagonism in experimental ischemic heart failure: hemodynamic, structural and neurohumoral effects.
Mulder P; Richard V; Thuillez C
Heart Fail Rev; 2001 Dec; 6(4):295-300. PubMed ID: 11447304
[TBL] [Abstract][Full Text] [Related]
43. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Wang QD; Li XS; Lundberg JM; Pernow J
Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
[TBL] [Abstract][Full Text] [Related]
44. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
[TBL] [Abstract][Full Text] [Related]
45. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
46. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
[TBL] [Abstract][Full Text] [Related]
47. Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist.
Ono K; Matsumori A; Shioi T; Furukawa Y; Sasayama S
Circulation; 1999 Oct; 100(17):1823-9. PubMed ID: 10534471
[TBL] [Abstract][Full Text] [Related]
48. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
Seccia TM; Belloni AS; Kreutz R; Paul M; Nussdorfer GG; Pessina AC; Rossi GP
J Am Coll Cardiol; 2003 Feb; 41(4):666-73. PubMed ID: 12598081
[TBL] [Abstract][Full Text] [Related]
49. YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
Fujimori A; Miyauchi T; Sakai S; Yuyama H; Iemitsu M; Sanagi M; Sudoh K; Goto K; Shikama H; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S354-7. PubMed ID: 15838319
[TBL] [Abstract][Full Text] [Related]
50. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.
Galiè N; Hinderliter AL; Torbicki A; Fourme T; Simonneau G; Pulido T; Espinola-Zavaleta N; Rocchi G; Manes A; Frantz R; Kurzyna M; Nagueh SF; Barst R; Channick R; Dujardin K; Kronenberg A; Leconte I; Rainisio M; Rubin L
J Am Coll Cardiol; 2003 Apr; 41(8):1380-6. PubMed ID: 12706935
[TBL] [Abstract][Full Text] [Related]
51. Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Lee TM; Lin MS; Chou TF; Chang NC
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1281-9. PubMed ID: 16565312
[TBL] [Abstract][Full Text] [Related]
52. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans.
Sütsch G; Bertel O; Kiowski W
Cardiovasc Drugs Ther; 1997 Jan; 10(6):717-25. PubMed ID: 9110115
[TBL] [Abstract][Full Text] [Related]
53. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
[TBL] [Abstract][Full Text] [Related]
54. Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats.
Vanecková I; Kramer HJ; Bäcker A; Schejbalová S; Vernerová Z; Eis V; Opocenský M; Dvorák P; Cervenka L
Vascul Pharmacol; 2006 Sep; 45(3):163-70. PubMed ID: 16807127
[TBL] [Abstract][Full Text] [Related]
55. Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats.
Lee TM; Lin MS; Chou TF; Tsai CH; Chang NC
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H220-7. PubMed ID: 15665062
[TBL] [Abstract][Full Text] [Related]
56. Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43.
Chen CC; Lien HY; Hsu YJ; Lin CC; Shih CM; Lee TM
J Appl Physiol (1985); 2010 Aug; 109(2):541-52. PubMed ID: 20466804
[TBL] [Abstract][Full Text] [Related]
57. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure.
Shimoyama H; Sabbah HN; Borzak S; Tanimura M; Shevlyagin S; Scicli G; Goldstein S
Circulation; 1996 Aug; 94(4):779-84. PubMed ID: 8772702
[TBL] [Abstract][Full Text] [Related]
58. A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart.
Purdham DM; Rajapurohitam V; Zeidan A; Huang C; Gross GJ; Karmazyn M
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H441-6. PubMed ID: 18469142
[TBL] [Abstract][Full Text] [Related]
59. Endothelin blockade in angiotensin II hypertension: prevention and treatment studies in the rat.
Ficai S; Herizi A; Mimran A; Jover B
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1100-3. PubMed ID: 11903325
[TBL] [Abstract][Full Text] [Related]
60. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
